Respiratory Disease News and Research

RSS

Physical activity and BMI related to lung function growth in children

A new study led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, sheds light on the growth of lung function in children.

15 Apr 2024

Study reveals lasting lung damage in tuberculosis survivors

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found compelling evidence that tuberculosis (TB) can have a lasting impact on the lungs of individuals who have been successfully treated for the disease.

15 Apr 2024

Unraveling gene regulation's role in pulmonary fibrosis

Regulators of gene expression are thought to play an outsized role in disorders from cancers to heart disease. But how exactly do variations in gene regulation translate into a disease's biology?

28 Mar 2024

Fine particulate matter exposure linked to increased hospital admissions for major diseases

Short and long term exposure to fine particulate matter (PM2.5) air pollution is linked to an increased risk of hospital admission for major heart and lung diseases, find two large US studies, published by The BMJ today.

21 Feb 2024

New study shows dramatic health benefits of quitting smoking

People who quit smoking see major gains in life expectancy after just a few years, according to a new study by University of Toronto researchers at Unity Health Toronto.

9 Feb 2024

Study tracks long COVID's shifting course in general population

Long COVID trajectories in a general population cohort show variable recovery patterns, with a portion of patients experiencing improvement, deterioration, or stable symptoms over time.

7 Feb 2024

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners.

From Enterprise Therapeutics Ltd 31 Jan 2024

More than half of Americans uninformed as heart disease claims top spot again

More than half of people in the U.S. (51%) do not know that heart disease is the leading cause of death in the country, according to a recent Harris Poll survey conducted on behalf of the American Heart Association in November 2023.

24 Jan 2024

Study shows engineered antibodies significantly boost Omicron neutralization

Researchers engineered IgA antibodies from IgG monoclonals, enhancing neutralization against Omicron by up to 75-fold and offering protection in mice models.

10 Jan 2024

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Racial residential segregation linked to widening health disparities

The U.S. must reduce racial residential segregation if it is to reduce racial disparities in health outcomes, according to a recently published study by researchers at Tufts University School of Medicine.

29 Nov 2023

New ingestible sensor for non-intrusive sleep disorder monitoring developed by MIT and collaborators

A recent Device study reported the effectiveness of an ingestible vitals-monitoring pill (VM pill) to monitor vital signs, including heart and respiratory rate based on a human trial.

24 Nov 2023

Study suggests non-prescription sales data can help to forecast respiratory disease fatalities

Researchers investigated the value of integrating sales of non-prescription medications (e.g., cough syrups) for improved forecasting of deaths from respiratory diseases in England using artificial intelligence (AI)-based predictive tools.

23 Nov 2023

Sales of respiratory medications key to predicting disease mortality, UK study finds

The value of integrating national longitudinal shopping data into respiratory disease forecasting models.

22 Nov 2023

Climate change could exacerbate respiratory disease deaths during warm seasons

Global warming caused by climate change could exacerbate the burden of inpatient mortality from respiratory diseases during the warm season.

7 Nov 2023

Can the planetary health diet save your life and the planet? Study finds mixed results

Adhering to a Planetary Health Diet (PHD), which emphasizes plant-based foods, was found to reduce risks of chronic diseases and death among Chinese Singaporeans, according to a new study. However, while higher PHD scores were linked to a 7% reduction in greenhouse gas emissions, they also resulted in increased land and water usage

26 Oct 2023

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

A recent study in the "Journal of Clinical Medicine" explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS). Findings revealed that a year after hospital discharge, over 91% of these patients suffered poor sleep quality, with nearly 59% experiencing insomnia, highlighting the lasting impact of COVID-19 on sleep health.

24 Oct 2023

Do overweight individuals exhibit reduced cardiopulmonary fitness after recovering from COVID-19?

Cardiopulmonary fitness, body composition, and persistent long COVID symptoms of individuals who had SARS-CoV-2 infections.

19 Oct 2023

Did the COVID-19 pandemic increase drunkness among people with a history of alcohol use disorder?

How COVID-19-related stressors altered drunkenness frequency.

10 Oct 2023

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

In a recent CDC's MMWR study, researchers found that while respiratory syncytial virus (RSV) infections are less common than COVID-19 and influenza in Americans aged 60+ years, they result in much more severe clinical outcomes. This insight supports the CDC's recommendation for RSV vaccination in older adults, emphasizing its potential in preventing severe respiratory disease.